An efficient early phase 2 procedure to screen medications for efficacy in smoking cessation by Perkins Kenneth A, Lerman Caryn in Psychopharmacology (2013). PubMed

Abstract

Initial screening of new medications for potential efficacy (i.e., Food and Drug Administration (FDA) early phase 2), such as in aiding smoking cessation, should be efficient in identifying which drugs do, or do not, warrant more extensive (and expensive) clinical testing.

[ hide abstract ]

Discussed In Paper

Related In Paper

Variant Annotations

None.